Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
The diagnosis of Alzheimer's disease can be improved by the use of biological measures.
Biomarkers of functional impairment, neuronal loss, and protein deposition that can be …
Biomarkers of functional impairment, neuronal loss, and protein deposition that can be …
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
The purpose of these guidelines is to assist physicians in recommending, performing,
interpreting and reporting the results of FDG PET/CT for oncological imaging of adult …
interpreting and reporting the results of FDG PET/CT for oncological imaging of adult …
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
neurological symptoms increasingly moved into the focus of interest. In this prospective …
neurological symptoms increasingly moved into the focus of interest. In this prospective …
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases
X Xiang, K Wind, T Wiedemann, T Blume… - Science translational …, 2021 - science.org
2-Deoxy-2-[18F] fluoro-d-glucose positron emission tomography (FDG-PET) is widely used
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …
to study cerebral glucose metabolism. Here, we investigated whether the FDG-PET signal is …
EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
The present procedural guidelines summarize the current views of the EANM Neuro-
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine …
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version …
These joint practice guidelines, or procedure standards, were developed collaboratively by
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …
the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and …
Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia
C Gasca-Salas, B Fernández-Rodríguez… - Nature …, 2021 - nature.com
MR-guided focused ultrasound (MRgFUS), in combination with intravenous microbubble
administration, has been applied for focal temporary BBB opening in patients with …
administration, has been applied for focal temporary BBB opening in patients with …
Positron emission tomography (PET) in oncology
A Gallamini, C Zwarthoed, A Borra - Cancers, 2014 - mdpi.com
Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …
Brain fluorodeoxyglucose (FDG) PET in dementia
T Kato, Y Inui, A Nakamura, K Ito - Ageing research reviews, 2016 - Elsevier
The purpose of this article is to present a selective and concise summary of
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …
18F-FDG PET in parkinsonism: differential diagnosis and evaluation of cognitive impairment
Accurate differential diagnosis of parkinsonism is of paramount therapeutic and prognostic
importance. In addition, with the development of invasive therapies and novel disease …
importance. In addition, with the development of invasive therapies and novel disease …